Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.080 | 12 | 12715152 | intron variant | G/A | snv | 0.38 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.080 | 12 | 12715152 | intron variant | G/A | snv | 0.38 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
12 | 12715767 | intron variant | C/T | snv | 7.0E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.120 | 12 | 12717384 | 5 prime UTR variant | TTCC/- | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 0.040 | 12 | 12717760 | 5 prime UTR variant | C/T | snv | 2.1E-04 |
|
Endocrine System Diseases | 0.700 | 0 | ||||||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2008 | 2013 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2008 | 2013 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.724 | 0.280 | 12 | 12717761 | 5 prime UTR variant | T/C | snv | 0.70 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 12 | 12717808 | 5 prime UTR variant | AGAG/- | delins | 3.8E-04 | 3.8E-04 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Endocrine System Diseases | 0.700 | 0 | |||||||||
|
0.925 | 0.120 | 12 | 12717808 | 5 prime UTR variant | AGAG/- | delins | 3.8E-04 | 3.8E-04 |
|
Endocrine System Diseases | 0.700 | 0 | |||||||||
|
1.000 | 0.120 | 12 | 12717887 | frameshift variant | GACG/- | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 0.120 | 12 | 12717896 | frameshift variant | -/AGGCGGAGCACCCCAAGCC | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
12 | 12717966 | stop gained | C/TAA | delins |
|
Neoplasms | 0.700 | 0 |